SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #2,555CAS 3区Hybrid

Journal of Neuroimmune Pharmacology

Abbreviation (ISO):J. NEUROIMMUNE PHARMACOL
Country: United States•WoS SCIE Quartile: Q1•Scopus SJR: 1.458•SCImago Rank: #2,555•Identifier (ISSN):1557-1890(Print)/1557-1904(Online)•Articles / Year: 60•Estimated Publication Fee (APC): $3,523 USD
Clarivate IF (2026)Q1
6.1
↑ +2.6

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
64

64 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate1.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
60articles/year
37.37% Gold OA•88.24% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 6.1)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 6.1)
🔵 Computed
20252.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.5)
🔵 Computed
20243.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.2)
🔵 Computed
20233.00đ
WoS Q1 có IF ≥ 5.0(IF: 6.2)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 7.285)
🔵 Computed
20212.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.147)
🔵 Computed
20202.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.113)
🔵 Computed
20192.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.87)
🔵 Computed
20182.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.664)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

The aims of the Journal of Neuroimmune Pharmacology are to promote the dissemination, interest, and exchange of new and important discoveries for the pharmacology and immunology of the nervous system. The aims parallel that of the Society on NeuroImmune Pharmacology by increasing the fundamental understanding of neurologic and neuropsychiatric disorders affected by the immune system or vice versa and towards pharmacologic measures that lead, either to a better understanding of disease mechanisms, or by improving disease outcomes. The scope of JNIP includes all primary works and reviews into the etiology, prevention, and treatment of neuroimmune and nervous system diseases affected by disordered immunity. Original studies serving to define neuroimmune modulation of environmental or endogenous cues such as toxins and drugs of abuse, hormones, and cytokines are welcome. JNIP will serve as a reliable source of interdisciplinary information bridging the fields of pharmacology, immunology, and neuroscience.

Topics Covered (Recognized by AI)
Medicine96.2%Biology96.1%Internal medicine86.8%Genetics78.6%Psychology73.3%Chemistry71.7%Immunology70.7%Biochemistry66.9%Neuroscience62.5%Pathology51.2%Endocrinology48.1%Psychiatry41%Pharmacology40.1%Disease39.9%Inflammation37.9%Receptor36.3%Immune system32.8%Cell biology30.8%Gene24.1%Virology21.8%Central nervous system20.2%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,555Scopus Q1SCImago Profile
Scopus Coverage:2006-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicineNeurosciencePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.458

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
99

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
6.07

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,523 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations797
3-Year Documents145
Citable Documents138

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ1
Immunology and AllergyQ1
Neuroscience (miscellaneous)Q1
PharmacologyQ1

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区NEUROSCIENCES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Springer US
Publication Language
English
Frequency
Quarterly
Founding Year
2006
Editorial Address
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
NEUROSCIENCES
JCRSCIE
49/330Q1
PHARMACOLOGY & PHARMACY
JCRSCIE
43/356Q1
NEUROSCIENCES
JCISCIE
48/330Q1
PHARMACOLOGY & PHARMACY
JCISCIE
44/356Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—3918
20253.5106489
20245.261723
20236.239624
20227.28518255
20214.147671,823
20204.113712,439
20193.87713,123
20183.664531,955
2017—521,954
2016—742,912
2015—773,580
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Journal of Neuroimmune Pharmacology

WoS Q1
2479201820192020202120222023202420253.50
Annual Impact Factor Metric
2025:3.5

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 29417423-2bfe-4726-93f0-79557acdbf54
Database Updated: 2026-09-28